Article
New York - Cholesterol-lowering statins and fibrates apparently aren't linked to a reduced risk of melanoma, researchers report.
New York - Cholesterol-lowering statins and fibrates apparently aren't linked to a reduced risk of melanoma, researchers report.
Investigators came to the conclusion after reviewing data from 20 randomized controlled trials involving almost 71,000 participants, according to the Nov. 1 issue of the Journal of the National Cancer Institute.
Twelve trials were for statins and eight for fibrates, Reuters reports.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.